Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 51.7 CHF 0.98%
Market Cap: 702.9m CHF
Have any thoughts about
Medartis Holding AG?
Write Note

Gross Margin
Medartis Holding AG

80.5%
Current
82%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
80.5%
=
Gross Profit
177.4m
/
Revenue
220.3m

Gross Margin Across Competitors

Country CH
Market Cap 702.1m CHF
Gross Margin
81%
Country JP
Market Cap 6.9T JPY
Gross Margin
86%
Country CH
Market Cap 37.7B CHF
Gross Margin
55%
Country DK
Market Cap 179.1B DKK
Gross Margin
68%
Country US
Market Cap 15.8B USD
Gross Margin
70%
Country CN
Market Cap 52B CNY
Gross Margin
72%
Country CA
Market Cap 6.3B USD
Gross Margin
61%
Country KR
Market Cap 9.1T KRW
Gross Margin
15%
Country US
Market Cap 6.2B USD
Gross Margin
65%
Country US
Market Cap 5.7B USD
Gross Margin
47%
Country UK
Market Cap 4.5B GBP
Gross Margin
56%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
702.1m CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
80.96 CHF
Undervaluation 36%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
80.5%
=
Gross Profit
177.4m
/
Revenue
220.3m
What is the Gross Margin of Medartis Holding AG?

Based on Medartis Holding AG's most recent financial statements, the company has Gross Margin of 80.5%.